市場調查報告書
商品編碼
1619017
心臟監測和心律管理設備的全球市場規模、佔有率和成長分析:按心臟監測設備類型、按心律管理設備類型、按程序、按應用、按最終用戶、按地區 - 行業預測(2024-2031 年) )年)Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Cardiac Monitoring Devices Type, By Cardiac Rhythm Management Devices Type, By Procedure, By Application, By End User, By Region- Industry Forecast 2024-2031 |
2022年全球心臟監測和心律管理設備市場規模估值為212億美元,從2023年的221.5億美元成長到2031年的315.1億美元,並預計在預測期內成長(2024年預計成長) 2019 年至2031 年複合年成長率為4.5%)。
由於心臟衰竭、心房顫動和遺傳性疾病等需要持續監測和管理的疾病的盛行率不斷增加,心律管理和監測設備市場正在經歷顯著成長。已開發和開發中地區日益成長的未滿足的醫療需求、生活方式的改變以及技術進步推動了這種擴張。人們對心臟病的認知不斷提高、醫療保健計劃的加強以及 MRI 相容設備的推出等因素進一步增強了市場動態。然而,我們也面臨人口老化、高血壓、糖尿病等文明病、社會經濟多樣性等風險因素所帶來的挑戰。此外,亞太地區的經濟成長預計將成為未來幾年市場發展的主要催化劑。
Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market size was valued at USD 21.2 billion in 2022 and is poised to grow from USD 22.15 billion in 2023 to USD 31.51 billion by 2031, growing at a CAGR of 4.5% during the forecast period (2024-2031).
The cardiac rhythm management and monitoring device market is experiencing significant growth driven by the increasing prevalence of conditions such as heart failure, atrial fibrillation, and genetic disorders, which require consistent monitoring and management. This expansion is fueled by rising unmet medical needs across both developed and developing regions, lifestyle changes, and advancements in technology. Factors like heightened awareness of cardiac disorders, robust healthcare programs, and the introduction of MRI-compatible devices are further enhancing market dynamics. However, the market also faces challenges presented by risk factors such as aging populations, lifestyle diseases like hypertension and diabetes, and socio-economic diversity. The Asia-Pacific region's economic growth is expected to be a major catalyst for market development in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segmental Analysis
Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market is segmented by cardiac monitoring devices type, cardiac rhythm management devices type, procedure, application, end user and region. Based on cardiac monitoring devices type, the market is segmented into ECG devices, MCT devices and com devices. Based on cardiac rhythm management devices type, the market is segmented into defibrillators and pacemakers. Based on procedure, the market is segmented into invasive procedures and non-invasive procedures. Based on application, the market is segmented into arrhythmias, myocardial infarction, heart failure and other applications. Based on end user, the market is segmented into hospitals, clinics, cardiac centers, ambulatory surgery centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market
The Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is significantly propelled by several key factors, notably the rising incidence of cardiovascular diseases. As these health issues become more prevalent, the demand for advanced monitoring and management devices has surged. Contributing to this growth are escalating healthcare costs associated with cardiac conditions, an increased shift towards ambulatory and home care services, favorable government policies, and ongoing technological advancements in medical devices. Innovations such as MRI-compatible pacemakers, subcutaneous implantable cardioverter defibrillators (ICDs), and Automated External Defibrillators (AEDs) are particularly impactful. In the United States, cardiovascular diseases remain a leading cause of mortality, accounting for approximately 25% of all deaths, further highlighting the need for effective monitoring and management solutions in this sector.
Restraints in the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market
The growth of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is significantly hindered by the high costs associated with these advanced medical devices, which can be prohibitive for many potential users. Additionally, the limitations in insurance coverage further exacerbate this challenge, as patients may find it difficult to afford the necessary treatments and monitoring solutions. This combination of steep pricing and inadequate insurance support presents substantial barriers to market penetration and adoption, ultimately restricting the overall expansion of this vital sector within the healthcare industry. Addressing these economic factors is crucial for facilitating broader access to these essential devices.
Market Trends of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market
The Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is witnessing a significant upward trajectory, driven by an increasing focus on comprehensive cardiovascular care that extends beyond traditional monitoring. With the dual emphasis on restoring and improving cardiac health, advancements in technology have enhanced device functionality, facilitating real-time data analysis and proactive intervention. This evolving landscape is further bolstered by rising life expectancy and a growing prevalence of cardiovascular diseases, leading to heightened demand for innovative solutions. Collaborations among leading biotech firms are accelerating research and development, leading to the emergence of sophisticated CRM technologies that not only manage but also heal.